TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action

Cancer immunotherapy has produced impressive clinical results in recent years. Despite the success of the checkpoint blockade strategies targeting cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death receptor 1 (PD-1), a large portion of cancer patients have not yet benefited from this nov...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Du, Wenwen, Yang, Min, Turner, Abbey, Xu, Chunling, Ferris, Robert L., Huang, Jianan, Kane, Lawrence P., Lu, Binfeng
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5372657/
https://ncbi.nlm.nih.gov/pubmed/28300768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18030645
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados